Phenoxyalkylamine compound
The invention provides a compound having a selective inhibitory activity against highly-expressed LAT-1 in tumor cell. The compound is represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof, and a LAT-1 inhibitor comprising the same.
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Osaka University KNC Laboratories Co., Ltd |
| description | The invention provides a compound having a selective inhibitory activity against highly-expressed LAT-1 in tumor cell. The compound is represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof, and a LAT-1 inhibitor comprising the same. |
| format | Patent |
| fullrecord | <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_09771316</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>09771316</sourcerecordid><originalsourceid>FETCH-uspatents_grants_097713163</originalsourceid><addsrcrecordid>eNrjZJAKyEjNy6-oTMzJrsxJzM3MS1VIzs8tyC_NS-FhYE1LzClO5YXS3AwKbq4hzh66pcUFiSWpeSXF8elFiSDKwNLc3NDY0MyYCCUAbiAkig</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Phenoxyalkylamine compound</title><source>USPTO Issued Patents</source><creator>Osaka University ; KNC Laboratories Co., Ltd</creator><creatorcontrib>Osaka University ; KNC Laboratories Co., Ltd</creatorcontrib><description>The invention provides a compound having a selective inhibitory activity against highly-expressed LAT-1 in tumor cell. The compound is represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof, and a LAT-1 inhibitor comprising the same.</description><language>eng</language><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/9771316$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,802,885,64038</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/9771316$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Osaka University</creatorcontrib><creatorcontrib>KNC Laboratories Co., Ltd</creatorcontrib><title>Phenoxyalkylamine compound</title><description>The invention provides a compound having a selective inhibitory activity against highly-expressed LAT-1 in tumor cell. The compound is represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof, and a LAT-1 inhibitor comprising the same.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZJAKyEjNy6-oTMzJrsxJzM3MS1VIzs8tyC_NS-FhYE1LzClO5YXS3AwKbq4hzh66pcUFiSWpeSXF8elFiSDKwNLc3NDY0MyYCCUAbiAkig</recordid><startdate>20170926</startdate><enddate>20170926</enddate><creator>Osaka University</creator><creator>KNC Laboratories Co., Ltd</creator><scope>EFH</scope></search><sort><creationdate>20170926</creationdate><title>Phenoxyalkylamine compound</title></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_097713163</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2017</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Osaka University</creatorcontrib><creatorcontrib>KNC Laboratories Co., Ltd</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><aucorp>Osaka University</aucorp><aucorp>KNC Laboratories Co., Ltd</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Phenoxyalkylamine compound</title><date>2017-09-26</date><risdate>2017</risdate><abstract>The invention provides a compound having a selective inhibitory activity against highly-expressed LAT-1 in tumor cell. The compound is represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof, and a LAT-1 inhibitor comprising the same.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_uspatents_grants_09771316 |
| source | USPTO Issued Patents |
| title | Phenoxyalkylamine compound |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T06%3A38%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.aucorp=Osaka%20University&rft.date=2017-09-26&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E09771316%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |